| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Dec―16 |
Linking thromboembolism to the pathogenesis of long COVID |
Frederik Denorme, Robert A. Campbell |
| 2 |
[GO] |
2025―Dec―16 |
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestry |
Art Schuermans, Andreas Verstraete, Vilma Lammi, Tomoko Nakanishi, Maddalena Ardissino, Jef Van den Eynde, Benjamin B. Sun, Marios K. Georgakis, Beatriz Guillen-Guio, Louise V. Wain, Christopher E. Brightling, Johan Van Weyenbergh, Adam J. Lewandowski, Betty Raman, Hugo Zeberg, Hanna M. Ollila, Stephen Burgess, Pradeep Natarajan, Michael C. Honigberg, Kathleen Freson, Thomas Vanassche, Peter Verhamme |
| 3 |
[GO] |
2025―Feb―24 |
The cellular and molecular cardiac tissue responses in human inflammatory cardiomyopathies after SARS-CoV-2 infection and COVID-19 vaccination |
Henrike Maatz, Eric L. Lindberg, Eleonora Adami, Natalia López-Anguita, Alvaro Perdomo-Sabogal, Lucía Cocera Ortega, Giannino Patone, Daniel Reichart, Anna Myronova, Sabine Schmidt, Ahmed Elsanhoury, Oliver Klein, Uwe Kühl, Emanuel Wyler, Markus Landthaler, Schayan Yousefian, Simon Haas, Florian Kurth, Sarah A. Teichmann, Gavin Y. Oudit, Hendrik Milting, Michela Noseda, Jonathan G. Seidman, Christine E. Seidman, Bettina Heidecker, Leif E. Sander, Birgit Sawitzki, Karin Klingel, Patrick Doeblin, Sebastian Kelle, Sophie Van Linthout, Norbert Hubner, Carsten Tschöpe |
| 4 |
[GO] |
2024―Oct―14 |
Endothelial cells as paracrine mediators of long COVID |
Simon R. Foster, James E. Hudson |
| 5 |
[GO] |
2024―Oct―14 |
CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID |
Dilip Thomas, Chikage Noishiki, Sadhana Gaddam, David Wu, Amit Manhas, Yu Liu, Dipti Tripathi, Nimish Kathale, Shaunak S. Adkar, Jaishree Garhyan, Chun Liu, Baohui Xu, Elsie G. Ross, Ronald L. Dalman, Kevin C. Wang, Anthony E. Oro, Karim Sallam, Jason T. Lee, Joseph C. Wu, Nazish Sayed |
| 6 |
[GO] |
2024―Aug―12 |
Dampening the immune response protects vascular integrity and reduces lung damage in respiratory syndromes |
Andrea Tavosanis |
| 7 |
[GO] |
2024―Feb―07 |
Abnormal complement activation is a sign of long COVID |
Elvira Forte |
| 8 |
[GO] |
2023―Oct―18 |
SARS-CoV-2 infection boosts inflammation in atherosclerotic plaques |
Mauro Giacca |
| 9 |
[GO] |
2023―Sep―28 |
SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels |
Natalia Eberhardt, Maria Gabriela Noval, Ravneet Kaur, Letizia Amadori, Michael Gildea, Swathy Sajja, Dayasagar Das, Burak Cilhoroz, O’ Jay Stewart, Dawn M. Fernandez, Roza Shamailova, Andrea Vasquez Guillen, Sonia Jangra, Michael Schotsaert, Jonathan D. Newman, Peter Faries, Thomas Maldonado, Caron Rockman, Amy Rapkiewicz, Kenneth A. Stapleford, Navneet Narula, Kathryn J. Moore, Chiara Giannarelli |
| 10 |
[GO] |
2023―Sep―11 |
Reply to: Risk of POTS after vaccine versus COVID-19 confounded |
Alan C. Kwan, Susan Cheng |
| 11 |
[GO] |
2023―Sep―11 |
Risk of POTS after vaccine versus COVID-19 confounded |
Ari R. Joffe |
| 12 |
[GO] |
2023―Sep―07 |
Author Correction: Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection |
Alan C. Kwan, Joseph E. Ebinger, Janet Wei, Catherine N. Le, Jillian R. Oft, Rachel Zabner, Debbie Teodorescu, Patrick G. Botting, Jesse Navarrette, David Ouyang, Matthew Driver, Brian Claggett, Brittany N. Weber, Peng-Sheng Chen, Susan Cheng |
| 13 |
[GO] |
2023―Jun―07 |
Cytokinopathy drives SARS-CoV-2 vaccination-associated myopericarditis |
Gerburg Schwaerzer |
| 14 |
[GO] |
2023―Feb―27 |
Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022 |
Lefei Han, Shi Zhao, Siyuan Li, Siyu Gu, Xiaobei Deng, Lin Yang, Jinjun Ran |
| 15 |
[GO] |
2023―Feb―08 |
Circulating spike protein may contribute to myocarditis after COVID-19 vaccination |
Elvira Forte |
| 16 |
[GO] |
2022―Dec―14 |
Potential POTS association with COVID-19 vaccination weaker than with COVID-19 infection |
|
| 17 |
[GO] |
2022―Dec―12 |
Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection |
Alan C. Kwan, Joseph E. Ebinger, Janet Wei, Catherine N. Le, Jillian R. Oft, Rachel Zabner, Debbie Teodorescu, Patrick G. Botting, Jesse Navarrette, David Ouyang, Matthew Driver, Brian Claggett, Brittany N. Weber, Peng-Sheng Chen, Susan Cheng |
| 18 |
[GO] |
2022―Dec―12 |
The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: it’s worth a shot |
Svetlana Blitshteyn, Artur Fedorowski |
| 19 |
[GO] |
2022―Nov―23 |
SARS-CoV-2 infection and cardiac arrhythmias |
Thomas A. Dewland, Gregory M. Marcus |
| 20 |
[GO] |
2022―Oct―24 |
COVID-19 and the amplification of cardiovascular risk by psychological distress |
Ian M. Kronish, Ari Shechter |
| 21 |
[GO] |
2022―Oct―03 |
Mild SARS-CoV-2 infection leaves long-lasting effects on cardiovascular health |
Vesna Todorovic |
| 22 |
[GO] |
2022―Mar―16 |
The pathological maelstrom of COVID-19 and cardiovascular disease |
Mauro Giacca, Ajay M. Shah |
|
